The UK government has awarded a £2.5 million contract to develop a secure global military medical records system, enabling deployed clinicians to view and share health data even offline.
For the first time, UCL researchers have used AI to identify two biologically distinct forms of multiple sclerosis, supporting the potential for more personalised care and improved treatment decisions for patients worldwide.
Open Access Government presents the policies of the Icelandic Ministry of the Environment, Energy, and Climate, which develops and enforces government policy on environmental issues.
The Horizon Europe Cluster 4 Industry calls continue to show strong engagement from Europe’s research and innovation community, with more than 800 proposals evaluated across single-stage and two-stage calls.
Cecilia Van Cauwenberghe explains how to measure the future using nanoscale metrology and discusses the global competition for technological superiority.
The NHS will prioritise menopause and prostate problems in its new digital hospital service, giving patients faster access to specialist care via the NHS App and remote consultations when the service launches in 2027.
NICE recommends natalizumab, including a lower-cost biosimilar, as a new treatment for adults with highly active relapsing-remitting multiple sclerosis, expanding options for thousands of patients.
The UK bioscience innovation community will come together again in spring 2026 as the Biotechnology and Biological Sciences Research Council (BBSRC) announces the return of its flagship Sparking Innovation Conference.
University of Sheffield researchers helped secure FDA approval for a new bone imaging method that could speed up osteoporosis drug trials, meaning new treatments may reach patients faster than ever.
As artificial intelligence continues to embed itself in the most important sectors, including healthcare, manufacturing, and mobility, concerns about cybersecurity and system resilience are growing just as quickly.
New Oxford University research reveals NHS England spends around 3% of its primary and secondary care budget, roughly £3 billion, on illnesses linked to extreme temperatures.
